New oral combo fights tough blood cancer in elderly and relapsed patients
NCT ID NCT04746235
Summary
This study is testing whether two oral drugs, venetoclax and ASTX727, can help control acute myeloid leukemia (AML). It is for adults whose AML has come back or hasn't responded to prior treatment, or for older, newly diagnosed patients who cannot tolerate strong chemotherapy. The goal is to see if this combination is safe and can effectively reduce or eliminate the leukemia cells.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.